MacLean Michael F Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$11.61M

Insider Activity of MacLean Michael F

According to the SEC Form 4 filings, MacLean Michael F, being in a position of

  1. Chief Financial Officer at Atrium Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 6516 shares for $471,650,
    over all time since 2024-01-22, has bought 0 shares, and sold 344539 shares for $12.17M.

Biography of MacLean Michael F

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $471,6502100

Comparison of Insiders on Amount of Buys and Sells

2026-01-21SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
4,542
0.003%
$72.45$329,068
2026-01-07SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
1,974
0.0015%
$72.23$142,582
2025-08-06SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
30,914
0.0286%
$42.73$1.32M
2025-03-20SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
7,935
0.0066%
$31.06$246,425
2025-01-21SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
3,287
0.0026%
$28.59$93,985
2024-12-18SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
11,151
0.0099%
$32.66$364,192
2024-11-06SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
41,137
0.0368%
$45.92$1.89M
2024-09-23SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
11,510
0.0099%
$44.00$506,440
2024-06-18SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
11,228
0.0086%
$39.13$439,345
2024-06-12SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
104,245
0.0725%
$35.72$3.72M
2024-05-14SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
75,000
0.0413%
$28.28$2.12M
2024-03-13SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
40,000
0.0191%
$24.52$980,760
2024-01-22SaleAvidity Biosciences, Inc.
RNA
Chief Financial Officer
1,616
0.0003%
$10.13$16,370
2010-08-02SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
9,542
0.004%
$56.85$542,457+17.61%
2010-03-19SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
3,757
0.0014%
$60.00$225,420-3.36%
2010-01-19SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
1,389
0.0005%
$55.00$76,395+2.34%
2008-10-06SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
2,047
0.0007%
$50.00$102,350-1.61%
2008-07-31SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
1,875
0.0004%
$47.77$89,569-30.47%
2008-07-22SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
682
0.0002%
$70.00$47,740-31.83%
2008-04-08SaleBiogen Inc.
BIIB
SVP, Chief Accounting Officer
2,214
0.0008%
$64.73$143,308-22.7%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.